Showing results (1081-1090 of 1,110) with videos related to
Sort By:
Pageof 111
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|May 11, 2022
Establishing a core outcome measure for life participation in patients receiving peritoneal dialysis: A Standardised Outcomes in Nephrology-Peritoneal Dialysis consensus workshop reportMelissa S Cheetham, Martin Wilkie, Fiona Loud, et al.Studies in Mycology|October 23, 2019
Genera of phytopathogenic fungi: GOPHY 3Y Marin-Felix, M Hernández-Restrepo, I Iturrieta-González, et al.Pediatric Blood & Cancer|October 27, 2006
The pediatric preclinical testing program: description of models and early testing resultsPeter J Houghton, Christopher L Morton, Chandra Tucker, et al.Biorxiv : the Preprint Server for Biology|April 8, 2024
RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.Journal of Translational Medicine|May 4, 2012
Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011"Paolo A Ascierto, Antonio M Grimaldi, Brendan Curti, et al.Annals of Surgical Oncology|February 18, 2014
Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patientsCharles M Balch, John F Thompson, Jeffrey E Gershenwald, et al.Journal of Medicinal Chemistry|October 6, 2018
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)Paul M Wehn, James P Rizzi, Darryl D Dixon, et al.Blood|February 22, 2013
Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variantJenny McIntosh, Peter J Lenting, Cecilia Rosales, et al.Nature Communications|December 22, 2019
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumorAndrew J Murphy, Xiang Chen, Emilia M Pinto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III TrialAngela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.Pageof 111